Research Topics
Genomes and GenesSpecies | A VickersSummaryAffiliation: Memorial Sloan-Kettering Cancer Center Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Systematic reviews of complementary therapies - an annotated bibliography. Part 1: acupunctureK Linde
Centre for Complementary Medicine Research, Department of Internal Medicine II, Technische Universitat, Munchen, Kaiserstr 9, 80801 München, Germany
BMC Complement Altern Med 1:3. 2001..Information on conditions, interventions, methods, results and conclusions was extracted using a pretested form and summarized descriptively...
A regret theory approach to decision curve analysis: a novel method for eliciting decision makers' preferences and decision-makingAthanasios Tsalatsanis
Center for Evidence based medicine and Health Outcomes Research, University of South Florida, Tampa, FL, USA
BMC Med Inform Decis Mak 10:51. 2010..We use the cognitive emotion of regret to serve as a link between systems 1 and 2 and to reformulate DCA...
Impact of recent screening on predicting the outcome of prostate cancer biopsy in men with elevated prostate-specific antigen: data from the European Randomized Study of Prostate Cancer Screening in Gothenburg, SwedenAndrew J Vickers
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA
Cancer 116:2612-20. 2010..However, the association between PSA and cancer probably depends on a man's recent screening history...
Safety and pharmacokinetic trial of docetaxel plus an Astragalus-based herbal formula for non-small cell lung cancer patientsBarrie R Cassileth
Integrative Medicine Service, Memorial Sloan Kettering Cancer Center, 1429 First Avenue at 74th Street, New York, NY 10021, USA
Cancer Chemother Pharmacol 65:67-71. 2009..To study a commonly used Astragalus-based herbal formula previously found effective in non-small cell lung cancer (NSCLC) on the pharmacokinetics of docetaxel in patients with NSCLC...
The clinically-integrated randomized trial: proposed novel method for conducting large trials at low costAndrew J Vickers
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, NY, NY 10021, USA
Trials 10:14. 2009..Unfortunately, contemporary randomized trials have become increasingly expensive, complex and burdened by regulation, so much so that many trials are of doubtful feasibility...
Counterpoint: Prostate-specific antigen velocity is not of value for early detection of cancerAndrew J Vickers
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
J Natl Compr Canc Netw 11:286-90. 2013..However, the literature clearly shows that simplistic application of PSA velocity cutoffs is not of value for early detection of prostate cancer...
Responses to the Acupuncture Trialists' Collaboration individual patient data meta-analysisAndrew J Vickers
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer, 307 East 63rd Street, 2nd Floor, New York, NY 10065, USA
Acupunct Med 31:98-100. 2013....
Acupuncture for chronic pain: individual patient data meta-analysisAndrew J Vickers
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
Arch Intern Med 172:1444-53. 2012..We aimed to determine the effect size of acupuncture for 4 chronic pain conditions: back and neck pain, osteoarthritis, chronic headache, and shoulder pain...
Who should be included in a clinical trial of screening for bladder cancer?: a decision analysis of data from the Prostate, Lung, Colorectal and Ovarian Cancer Screening TrialAndrew J Vickers
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA
Cancer 119:143-9. 2013..Data from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial were used and simple decision analytic techniques were applied to compare different eligibility criteria for a screening trial...
Individualized estimation of the benefit of radical prostatectomy from the Scandinavian Prostate Cancer Group randomized trialAndrew Vickers
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Eur Urol 62:204-9. 2012..Although there is randomized evidence that radical prostatectomy improves survival, there are few data on how benefit varies by baseline risk...
Against quantiles: categorization of continuous variables in epidemiologic research, and its discontentsCaroline Bennette
Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, WA 98195 7630, USA
BMC Med Res Methodol 12:21. 2012....
Predicting prostate cancer many years before diagnosis: how and why?Andrew J Vickers
Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
World J Urol 30:131-5. 2012..Men with the top 10% of PSAs at a young age (PSA ~1.5 ng/ml or higher below 50) are at particularly high risk and should be subject to intensive monitoring...
Feasibility study of a clinically-integrated randomized trial of modifications to radical prostatectomyAndrew J Vickers
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 11215, USA
Trials 13:23. 2012..We aimed to determine the feasibility of implementing such a trial for radical prostatectomy...
Preparing raw clinical data for publication: guidance for journal editors, authors, and peer reviewersIain Hrynaszkiewicz
BioMed Central, 236 Gray s Inn Road, London WC1X 8HL, UK
Trials 11:9. 2010..Basic advice on file preparation is provided along with procedural guidance on prospective and retrospective publication of raw data, with an emphasis on randomised controlled trials...
Statistical methods to correct for verification bias in diagnostic studies are inadequate when there are few false negatives: a simulation studyAngel M Cronin
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, NY, NY 10021, USA
BMC Med Res Methodol 8:75. 2008..Data from such studies are subject to what has been termed "verification bias". We evaluated statistical methods for verification bias correction when there are few false negatives...
Prostate-specific antigen at or before age 50 as a predictor of advanced prostate cancer diagnosed up to 25 years later: a case-control studyDavid Ulmert
Departments of Laboratory Medicine and Clinical Sciences in Malmö, Lund University, University Hospital UMAS, Malmo, Sweden
BMC Med 6:6. 2008..We aimed to determine whether this association holds for advanced cancers, defined as clinical stage T3 or higher, or skeletal metastasis at the time of the cancer diagnosis...
Systematic reviews of complementary therapies - an annotated bibliography. Part 2: herbal medicineK Linde
Centre for Complementary Medicine Research, Department of Internal Medicine II, Technische Universitat, Munchen, Kaiserstr 9, 80801 München, Germany
BMC Complement Altern Med 1:5. 2001..Information on conditions, interventions, methods, results and conclusions was extracted using a pre-tested form and summarized descriptively...
Systematic reviews of complementary therapies - an annotated bibliography. Part 3: homeopathyK Linde
Centre for Complementary Medicine Research, Department of Internal Medicine II, Technische Universitat, Munchen, Kaiserstr 9, 80801 München, Germany
BMC Complement Altern Med 1:4. 2001..Information on conditions, interventions, methods, results and conclusions was extracted using a pretested form and summarized descriptively...
Individual patient data meta-analysis of acupuncture for chronic pain: protocol of the Acupuncture Trialists' CollaborationAndrew J Vickers
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
Trials 11:90. 2010..The Acupuncture Trialists' Collaboration, a group of trialists, statisticians and other researchers, was established to synthesize patient-level data from several recently published large, high-quality trials...
Multiple assessment in quality of life trials: how many questionnaires? How often should they be given?Andrew J Vickers
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Soc Integr Oncol 4:135-8. 2006..Decisions about the appropriate number of assessments to use can be based on statistical properties derived from simple formulae...
How to measure quality of life in integrative oncology researchAndrew J Vickers
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Soc Integr Oncol 4:100-3. 2006..In many cases, it is preferable to use specific symptoms, such as pain or fatigue, as opposed to more generic quality of life scales...
Systematic review of pretreatment prostate-specific antigen velocity and doubling time as predictors for prostate cancerAndrew J Vickers
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Clin Oncol 27:398-403. 2009..We aimed to assess the published evidence for the clinical utility of PSA dynamics in this population...
Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markersAndrew J Vickers
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 307 East 63rd Street, New York, NY 10065, USA
BMC Med Inform Decis Mak 8:53. 2008..Most critically, decision curve analysis can be applied directly to a data set, and does not require the sort of external data on costs, benefits and preferences typically required by traditional decision analytic techniques...
Screening for prostate cancer: early detection or overdetection?Andrew J Vickers
Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
Annu Rev Med 63:161-70. 2012..In current U.S. practice, however, many men who are screened are unlikely to benefit, most men found to have low-risk cancers are referred for unnecessary curative treatment, and much treatment is given at low-volume centers...
Against diagnosisAndrew J Vickers
Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Ann Intern Med 149:200-3. 2008..The authors compare and contrast the diagnostic and risk prediction approaches and attempt to identify the types of medical problem to which each is best suited...
A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, SwedenAndrew J Vickers
Memorial Sloan Kettering Cancer Center, Department of Epidemiology and Biostatistics, East 63rd Street, New York, NY 10021, USA
BMC Med 6:19. 2008..We set out to determine whether a multivariable model including four kallikrein forms (total, free, and intact PSA, and human kallikrein 2 (hK2)) could predict prostate biopsy outcome in previously unscreened men with elevated total PSA...
Basic introduction to research: how not to do researchAndrew J Vickers
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Soc Integr Oncol 6:82-5. 2008..As such, it is doubly important that clinical research is conducted by those with appropriate training, statistical help, and institutional support...
Systematic review of statistical methods used in molecular marker studies in cancerAndrew J Vickers
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York City, New York 10021, USA
Cancer 112:1862-8. 2008..In the current study, the experimental designs and statistical methods used in contemporary molecular marker studies are reviewed, particularly with respect to whether these evaluated a marker's clinical value...
Living proof and the pseudoscience of alternative cancer treatmentsAndrew J Vickers
Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Soc Integr Oncol 6:37-40. 2008..It also suggests that little progress has been made in the conventional treatment of myeloma. This is highly misleading and may lead to cancer patients rejecting effective treatments...
The learning curve for surgical margins after open radical prostatectomy: implications for margin status as an oncological end pointAndrew Vickers
Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
J Urol 183:1360-5. 2010..Surgical margin status is commonly used as an end point for surgical learning. We examined the surgical margin learning curve and investigated whether surgical margins are a good marker for oncological outcome...
Effects of pathologic stage on the learning curve for radical prostatectomy: evidence that recurrence in organ-confined cancer is largely related to inadequate surgical techniqueAndrew J Vickers
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Eur Urol 53:960-6. 2008..We previously demonstrated that there is a learning curve for open radical prostatectomy. We sought to determine whether the effects of the learning curve are modified by pathologic stage...
Which botanicals or other unconventional anticancer agents should we take to clinical trial?Andrew J Vickers
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Soc Integr Oncol 5:125-9. 2007....
The surgical learning curve for prostate cancer control after radical prostatectomyAndrew J Vickers
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
J Natl Cancer Inst 99:1171-7. 2007..We analyzed the surgical learning curve for prostate cancer recurrence after radical prostatectomy...
How to improve accrual to clinical trials of symptom control 2: design issuesAndrew J Vickers
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Soc Integr Oncol 5:61-4. 2007..Patient burden can be reduced by limiting the number of hospital visits and avoiding excessive numbers of questionnaires...
How to improve accrual to clinical trials of symptom control 1: recruitment strategiesAndrew J Vickers
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Soc Integr Oncol 5:38-42. 2007..The information given to patients during any initial contact should be as simple and general as possible: presenting too much information too soon can be overwhelming and off-putting...
Long-term health outcomes of a decision aid: data from a randomized trial of adjuvant! In women with localized breast cancerAndrew J Vickers
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, USA
Med Decis Making 29:461-7. 2009..The authors aimed to model the effects of the Adjuvant! decision aid on expected survival in women with early stage breast cancer. PATIENTS and..
The surgical learning curve for laparoscopic radical prostatectomy: a retrospective cohort studyAndrew J Vickers
Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Lancet Oncol 10:475-80. 2009..Here we aim to characterise the learning curve for laparoscopic radical prostatectomy...
Data and programming code from the studies on the learning curve for radical prostatectomyAndrew J Vickers
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, NY, USA
BMC Res Notes 3:234. 2010..Data include markers of cancer severity (stage, grade and prostate-specific antigen level), cancer outcome, and surgeon variables such as training and experience...
The relationship between prostate-specific antigen and prostate cancer risk: the Prostate Biopsy Collaborative GroupAndrew J Vickers
Memorial Sloan Kettering Cancer Center, New York, NY, USA
Clin Cancer Res 16:4374-81. 2010..We hypothesized that the risk of prostate cancer on biopsy for a given PSA level is affected by identifiable characteristics of the cohort under study...
Validation study of a web-based assessment of functional recovery after radical prostatectomyAndrew J Vickers
Department of Epidemiology and Biostatistics, Health Outcomes Group Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA
Health Qual Life Outcomes 8:82. 2010..Logistical problems associated with using paper questionnaire limit their use in the clinic. We have implemented a web-interface ("STAR") for patient-reported outcomes after radical prostatectomy...
Prostate specific antigen velocity does not aid prostate cancer detection in men with prior negative biopsyAndrew J Vickers
Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
J Urol 184:907-12. 2010..We determined whether prostate specific antigen velocity could predict repeat biopsy results in men with persistently increased prostate specific antigen after initial negative biopsy...
Cancer control and functional outcomes after radical prostatectomy as markers of surgical quality: analysis of heterogeneity between surgeons at a single cancer centerAndrew Vickers
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Eur Urol 59:317-22. 2011..Data on urinary and erectile outcomes, however, are lacking...
Reducing unnecessary biopsy during prostate cancer screening using a four-kallikrein panel: an independent replicationAndrew Vickers
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Clin Oncol 28:2493-8. 2010..We aimed to replicate our findings in a large, independent, representative, population-based cohort...
A four-kallikrein panel predicts prostate cancer in men with recent screening: data from the European Randomized Study of Screening for Prostate Cancer, RotterdamAndrew J Vickers
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Clin Cancer Res 16:3232-9. 2010..Although this model accurately predicts the result of biopsy in unscreened men, its properties for men with a history of PSA screening have not been fully characterized...
How do you tell whether a change in surgical technique leads to a change in outcome?Andrew J Vickers
Department of Epidemiology and Biostatistics and Urology Service, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
J Urol 183:1510-4. 2010..Simple comparison of results before and after surgical modification may be confounded by the surgical learning curve. We developed a statistical method applicable to analyzing before/after surgical studies...
Traditional statistical methods for evaluating prediction models are uninformative as to clinical value: towards a decision analytic frameworkAndrew J Vickers
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
Semin Oncol 37:31-8. 2010..Such decision analytic techniques hold the promise of determining whether clinical implementation of prediction models would do more good than harm...
One statistical test is sufficient for assessing new predictive markersAndrew J Vickers
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 44, New York, NY 10065 USA
BMC Med Res Methodol 11:13. 2011..These two steps often lead to discordant conclusions...
Finasteride to prevent prostate cancer: should all men or only a high-risk subgroup be treated?Andrew J Vickers
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 307 East 63rd St, New York, NY 10021, USA
J Clin Oncol 28:1112-6. 2010..Clinicians who believe that it is unnecessary to prevent all cancers, but that preventing those readily detectable by screening would be desirable, would be best off recommending finasteride only to a high-risk subgroup...
An empirical evaluation of guidelines on prostate-specific antigen velocity in prostate cancer detectionAndrew J Vickers
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Natl Cancer Inst 103:462-9. 2011....
Clinical benefits of a multivariate prediction model for bladder cancer: a decision analytic approachAndrew J Vickers
Department of Epidemiology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Cancer 115:5460-9. 2009....
Prostate-specific antigen velocity for early detection of prostate cancer: result from a large, representative, population-based cohortAndrew J Vickers
Memorial Sloan Kettering Cancer Center, Department of Epidemiology and Biostatistics, 307 E 63rd St, New York, NY 10021, USA
Eur Urol 56:753-60. 2009..It has been suggested that changes in prostate-specific antigen (PSA) over time (ie, PSA velocity [PSAV]) aid prostate cancer detection. Some guidelines do incorporate PSAV cut points as an indication for biopsy...
Phase II designs for anticancer botanicals and supplementsAndrew J Vickers
Department of Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Soc Integr Oncol 7:35-40. 2009..Such a design asks whether patients treated by the new agent are doing better than expected; if so, this suggests that the agent should be tested further in phase III trials...
Surgery confounds biology: the predictive value of stage-, grade- and prostate-specific antigen for recurrence after radical prostatectomy as a function of surgeon experienceAndrew J Vickers
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Int J Cancer 128:1697-702. 2011..Although our findings have no direct clinical implications, studies investigating biological variables as predictors of outcome after curative resection of cancer should consider the impact of surgeon-specific factors...
Setting the bar in phase II trials: the use of historical data for determining "go/no go" decision for definitive phase III testingAndrew J Vickers
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Clin Cancer Res 13:972-6. 2007..We sought to determine the proportion of phase II trials that require historical data to establish the null and to determine how these historical estimates were derived...
Why use placebos in clinical trials? A narrative review of the methodological literatureA J Vickers
Integrative Medicine Service and Biostatistics Service, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 11215, USA
J Clin Epidemiol 53:157-61. 2000..Placebo-controlled trials have high internal validity but may be difficult to apply to clinical practice; the situation is reversed for trials without placebo control...
Acupuncture for postchemotherapy fatigue: a phase II studyAndrew J Vickers
Intergrative Medicine Service, and Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Clin Oncol 22:1731-5. 2004..To determine whether improvement in postchemotherapy fatigue following acupuncture treatment is substantial enough to warrant a controlled trial...
Statistical considerations for use of composite health-related quality-of-life scores in randomized trialsAndrew J Vickers
Integrative Medicine Service, Biostatistics Service, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Qual Life Res 13:717-23. 2004..There may be several clinically and scientifically reasonable alternative combinations of subscales for the primary outcome measure...
Statistical reanalysis of four recent randomized trials of acupuncture for pain using analysis of covarianceAndrew J Vickers
Integrative Medicine Service, Biostatistics Service, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Clin J Pain 20:319-23. 2004..Each trial used statistical methods that did not adjust for baseline pain scores and were thus of suboptimal power. The objective of this study is to reanalyze the trials using analysis of covariance (ANCOVA)...
How to randomizeAndrew J Vickers
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Soc Integr Oncol 4:194-8. 2006..Computer randomization can easily incorporate extensions of randomization, such as blocking, stratification, and minimization, which can help ensure balance between groups...
Analysis of variance is easily misapplied in the analysis of randomized trials: a critique and discussion of alternative statistical approachesAndrew J Vickers
Integrative Medicine Service, Biostatistics Service, Department of Medicine, MSKCC, New York, NY 10021, USA
Psychosom Med 67:652-5. 2005..Given that ANOVA is easily misapplied in the analysis of randomized trials, alternative approaches such as regression methods should be considered in preference...
Parametric versus non-parametric statistics in the analysis of randomized trials with non-normally distributed dataAndrew J Vickers
Integrative Medicine Service, Biostatistics Service, Memorial Sloan Kettering Cancer Center, Howard 1312a, New York, NY 10021, USA
BMC Med Res Methodol 5:35. 2005....
Unconventional anticancer agents: a systematic review of clinical trialsAndrew J Vickers
Integrative Medicine Service and Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Clin Oncol 24:136-40. 2006..The objective of this study was to review systematically the methodologies applied in clinical trials of unconventional treatments specifically for cancer...
Interpreting data from randomized trials: the Scandinavian prostatectomy study illustrates two common errorsAndrew Vickers
Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
Nat Clin Pract Urol 2:404-5. 2005
Homoeopathic Oscillococcinum for preventing and treating influenza and influenza-like syndromesA J Vickers
Memorial Sloan Kettering Cancer Center, Integrative Medicine Service, 1275 York Avenue, New York, NY 10021, USA
Cochrane Database Syst Rev 3:CD001957. 2006..The rationale for its use in influenza comes from the homoeopathic principle of 'let like be cured by like'. This medicine is manufactured from wild duck heart and liver, which are said to be reservoirs for influenza viruses...
Does a delay between diagnosis and radical prostatectomy increase the risk of disease recurrence?Andrew J Vickers
Department of Urology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Cancer 106:576-80. 2006..In the current study, the authors evaluated whether time from biopsy to radical prostatectomy (RP) was predictive of postoperative biochemical disease recurrence (BCR)...
How to design a phase I trial of an anticancer botanicalAndrew J Vickers
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Soc Integr Oncol 4:46-51. 2006..Increasing the use of phase I methodology would ensure a more systematic development of botanicals as anticancer agents. This would likely increase the chance that at least one such agent would be proven to extend lives...
Acupuncture for chronic headache in primary care: large, pragmatic, randomised trialAndrew J Vickers
Integrative Medicine Service, Biostatistics Service, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, NY, NY 10021, USA
BMJ 328:744. 2004..To determine the effects of a policy of "use acupuncture" on headache, health status, days off sick, and use of resources in patients with chronic headache compared with a policy of "avoid acupuncture."..
Use of a single global assessment to reduce missing data in a clinical trial with follow-up at one yearAndrew J Vickers
Integrative Medicine Service, Biostatistics Service, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Control Clin Trials 24:731-5. 2003..Further research might usefully examine the value of global assessment for imputation of missing data in a variety of different settings...
How many repeated measures in repeated measures designs? Statistical issues for comparative trialsAndrew J Vickers
Integrative Medicine Service, Biostatistics Service, Memorial Sloan Kettering Cancer Center, Howard 13, 1275 York Avenue NY, NY 10021, USA
BMC Med Res Methodol 3:22. 2003..There has been little guidance in the literature as to selecting the optimal number of repeated measures...
Message to complementary and alternative medicine: evidence is a better friend than powerA J Vickers
Integrative Medicine, Biostatistics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, USA
BMC Complement Altern Med 1:1. 2001..A significant constituency within CAM, however, appears to have substantive doubts about EBM and some are expressly hostile...
The use of percentage change from baseline as an outcome in a controlled trial is statistically inefficient: a simulation studyA J Vickers
Integrative Medicine Service, Biostatistics Service, Memorial Sloan Kettering Cancer Center, 1275 York Avenue New York, New York 10021, USA
BMC Med Res Methodol 1:6. 2001..The statistical power of each method was determined for a hypothetical randomized trial under a range of correlations between baseline and post-treatment scores...
Unconventional therapies for cancer and cancer-related symptomsA J Vickers
Integrative Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Lancet Oncol 2:226-32. 2001..Such complementary therapies are increasingly provided at mainstream cancer centres...
Decision curve analysis: a novel method for evaluating prediction modelsAndrew J Vickers
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, USA
Med Decis Making 26:565-74. 2006....
How to reduce the number of patients needed for randomized trials: a basic introductionA Vickers
Integrative Medicine Service, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Complement Ther Med 9:234-6. 2001..There are considerable economic and ethical advantages to reducing sample size by a third; however, ANCOVA is statistically complex and expert statistical help is required...
Botanical medicines for the treatment of cancer: rationale, overview of current data, and methodological considerations for phase I and II trialsAndrew Vickers
Integrative Medicine Service, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Cancer Invest 20:1069-79. 2002..Phase I and II methodology is also problematic: botanicals have low toxicity and are unlikely to cause rapid tumor regression. There is currently minimal regulation of botanical medicines...
Underpowering in randomized trials reporting a sample size calculationAndrew J Vickers
Integrative Medicine Service, Biostatistics Service, Memorial Sloan Kettering Cancer Center, Howard 1312a, 1275 York Avenue, NY 10021, USA
J Clin Epidemiol 56:717-20. 2003..The objective of this study was to determine whether standard deviations (SDs) used in sample size calculations are smaller than those found in the resulting study sample, thereby leading to underpowered studies...
A panel of kallikrein markers can predict outcome of prostate biopsy following clinical work-up: an independent validation study from the European Randomized Study of Prostate Cancer screening, FranceAmine Benchikh
Hopital Bichat Claude Bernard, Paris, France
BMC Cancer 10:635. 2010..Here we investigate the properties of our panel in men subject to clinical work-up before biopsy...
Impact of a multidisciplinary continuous quality improvement program on the positive surgical margin rate after laparoscopic radical prostatectomyKarim Touijer
Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
Eur Urol 49:853-8. 2006....
Risk-adjusted analysis of positive surgical margins following laparoscopic and retropubic radical prostatectomyKarim Touijer
Department of Urology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Eur Urol 52:1090-6. 2007..To prospectively compare in a contemporary and contemporaneous series the positive surgical margin (PSM) rate between laparoscopic (LRP) and retropubic (RRP) radical prostatectomy at the same institution...
Alternative medicine use worldwide: the International Union Against Cancer surveyB R Cassileth
Integrative Medicine Service, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Cancer 91:1390-3. 2001..In the current study, the authors attempted to surmount the deficiencies of previous surveys and elicit information regarding the use of alternative treatments of cancer worldwide...
Evaluation of widely consumed botanicals as immunological adjuvantsGovind Ragupathi
Laboratory of Tumor Vaccinology, Melanoma and Sarcoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, United States
Vaccine 26:4860-5. 2008..We describe here the results obtained using this s.c. immunization model with seven botanicals purported to have immune stimulant effects...
Randomized controlled trial of a special acupuncture technique for pain after thoracotomyGary Deng
Integrative Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
J Thorac Cardiovasc Surg 136:1464-9. 2008..We sought to determine whether an acupuncture technique specially developed for a surgical oncology population (intervention) reduces pain or analgesic use after thoracotomy compared with a sham acupuncture technique (control)...
Rituximab therapy of lymphoma is enhanced by orally administered (1-->3),(1-->4)-D-beta-glucanShakeel Modak
Department of Pediatrics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, USA
Leuk Res 29:679-83. 2005..No clinical toxicity was observed. The therapeutic efficacy and lack of toxicity of this combination supports further investigation into its clinical utility...
Sialyltransferase STX (ST8SiaII): a novel molecular marker of metastatic neuroblastomaIrene Y Cheung
Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Int J Cancer 119:152-6. 2006..Similarly, the STX transcript level of posttreatment marrows was also highly prognostic of outcome (PFS, p = 0.001; OS, p < 0.0005). We conclude that STX mRNA has potential clinical utility as a molecular marker of metastatic NB...
Comprehensive prospective comparative analysis of outcomes between open and laparoscopic radical prostatectomy conducted in 2003 to 2005Karim Touijer
Department of Surgery, Service of Urology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
J Urol 179:1811-7; discussion 1817. 2008..In a nonrandomized prospective fashion we compared the oncological, functional and morbidity outcomes after laparoscopic and retropubic radical prostatectomy...
Orally administered beta-glucans enhance anti-tumor effects of monoclonal antibodiesNai Kong V Cheung
Department of Pediatrics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Cancer Immunol Immunother 51:557-64. 2002..Given the favorable efficacy and toxicity profile of oral beta- D-glucan treatment, the role of natural products that contain beta-glucan in cancer treatment as an enhancer of the effect of mAb therapy deserves further study...
Metastasis after radical prostatectomy or external beam radiotherapy for patients with clinically localized prostate cancer: a comparison of clinical cohorts adjusted for case mixMichael J Zelefsky
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
J Clin Oncol 28:1508-13. 2010..We assessed the effect of radical prostatectomy (RP) and external beam radiotherapy (EBRT) on distant metastases (DM) rates in patients with localized prostate cancer treated with RP or EBRT at a single specialized cancer center...
Complications after radical and partial nephrectomy as a function of ageWilliam T Lowrance
Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
J Urol 183:1725-30. 2010..We determined if the association of age and perioperative outcomes differed between nephrectomy types...
Predicting teratoma in the retroperitoneum in men undergoing post-chemotherapy retroperitoneal lymph node dissectionBrett S Carver
Department of Urology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
J Urol 176:100-3; discussion 103-4. 2006..We evaluated patients undergoing post-chemotherapy retroperitoneal lymph node dissection for nonseminomatous germ cell tumors to determine predictors of teratomatous elements in the retroperitoneum...
Randomized, controlled trial of acupuncture for the treatment of hot flashes in breast cancer patientsGary Deng
Memorial Sloan Kettering Cancer Center, 1429 First Ave, New York, NY 10021, USA
J Clin Oncol 25:5584-90. 2007..To determine the immediate and long-term effects of true acupuncture versus sham acupuncture on hot flash frequency in women with breast cancer...
Cyclin D1, a novel molecular marker of minimal residual disease, in metastatic neuroblastomaIrene Y Cheung
Department of Pediatrics, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
J Mol Diagn 9:237-41. 2007..We conclude that CCND1 has potential clinical utility as a novel molecular marker of MRD in the bone marrow of patients with metastatic NB...
Acupuncture: integration into cancer careGary Deng
Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Soc Integr Oncol 4:86-92. 2006..Acupuncture is useful complementary therapy in cancer care. Its integration into regular oncology practice can improve the supportive care of cancer patients...
Cytoreductive nephrectomy and nephrectomy/complete metastasectomy for metastatic renal cancerPaul Russo
Department of Surgery, Urology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
ScientificWorldJournal 7:768-78. 2007..This surgical experience provides a contemporary foundation as new targeted therapeutic agents are integrated into the neoadjuvant or adjuvant treatment of locally advanced and metastatic renal cancer...
Free PSA isoforms and intact and cleaved forms of urokinase plasminogen activator receptor in serum improve selection of patients for prostate cancer biopsyThomas Steuber
Department of Urology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Int J Cancer 120:1499-504. 2007..0.715, p=0.039). In this setting, hK2 did not add diagnostic information. Measurements of individual forms of suPAR and PSA isoforms contributed significantly to discrimination of men with PCa from those with no evidence of malignancy...
Significance of intraoperative ureteral evaluation at radical cystectomy for urothelial cancerGanesh V Raj
Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
Cancer 107:2167-72. 2006..However, the overall risk of recurrence is low and is not clearly associated with overall survival. The data do not support routine intraoperative frozen sections to assess ureteral involvement...
AcupunctureA Vickers
Memorial Sloan-Kettering Cancer Center, New York, USA
Qual Saf Health Care 11:92-7. 2002
Positive surgical margins and accessory pudendal artery preservation during laparoscopic radical prostatectomyFernando P Secin
Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Eur Urol 48:786-92; discussion 793. 2005..APA preservation can be undertaken without compromise to the oncological integrity of the laparoscopic radical prostatectomy...
Significance of non-calcified pulmonary nodules in patients with extrapulmonary cancersS Khokhar
Division of Pulmonary Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Thorax 61:331-6. 2006..In smokers, such lesions should raise concern for lung cancer...
Evaluation of regional lymph node dissection in patients with upper urinary tract urothelial cancerFernando P Secin
Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Int J Urol 14:26-32. 2007..We evaluated the manner in which the LND was applied at NU, the patterns of lymph node (LN) involvement and the preoperative variables that could identify patients at high risk for lymph node metastasis (LNM)...
The learning curve for laparoscopic radical prostatectomy: an international multicenter studyFernando P Secin
Department of Urology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
J Urol 184:2291-6. 2010..We estimated the learning curve of laparoscopic radical prostatectomy for positive surgical margins compared to a published learning curve for open radical prostatectomy...
Preoperative and intraoperative risk factors for side-specific positive surgical margins in laparoscopic radical prostatectomy for prostate cancerFernando P Secin
Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY 10021, United States
Eur Urol 51:764-71. 2007..Our objective was to determine preoperative risk factors and the association of ipsilateral degree of neurovascular bundle dissection (intraoperative factor) with side-specific PSMs in these patients...
Research Grants
- Methodology of Phase I and II trials of anticancer CAMAndrew Vickers; Fiscal Year: 2004....
